EndoGene.Bio
Endogene.bio was founded to solve the lack of molecular data that keeps endometriosis a clinical black box. By analyzing key cells in menstrual blood, the company delivers tissue-level insights with the convenience of a liquid biopsy. Its platform integrates a proprietary database of single-cell epigenetics, transcriptomics with omics ML advanced algorithms to enable earlier diagnosis, patient stratification, and targeted drug discovery. With proprietary datasets, clinical validation, and pharma interest, endogene.bio is unlocking molecular medicine in a €180B+ women’s health market.
Tech Stack (5 technologies)
Frequently Asked Questions
What technologies does EndoGene.Bio use?+
EndoGene.Bio uses 5 technologies including Next.js, React, HSTS.
What industry is EndoGene.Bio in?+
EndoGene.Bio operates in the Analytics industry.
Where is EndoGene.Bio based?+
EndoGene.Bio is headquartered in France.
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026